| 引用本文：孙静.制定和落实国家药物政策的国际进展及启示[J].中国卫生政策研究,2012,5(11):12-18 |
|
| 制定和落实国家药物政策的国际进展及启示 |
| 投稿时间：2012-07-12 修订日期：2012-10-18 PDF全文浏览 HTML全文浏览 |
| 孙静1 |
| 卫生部医院管理研究所 |
| 摘要:通过参加第二届国家药物政策国际大会获得的信息及文献，回顾国际社会推行国家药物政策的发展历程及最新进展，总结欧洲、澳大利亚及相关国家和地区的典型经验，从中提炼我国可借鉴的经验如下：制定和执行国家药物政策，首先是一个政治过程，然后才是技术过程；确定执行主体，规定清晰的权利和义务，在健全的卫生体系下，制定可操作的执行策略是国家药物政策焕发活力的关键；活跃的社会团体可以帮助表达各方意愿，使国家药物政策代表更广泛的民意；国家药物政策服务的主体是消费者，以消费者为中心、让消费者的意见不被忽略，可以提高消费者对政策的认同感；国家药物政策是国家卫生政策的一部分，需要全面、细致的政策设计，平衡健康目标与医药产业发展目标。 |
| 关键词:卫生政策 卫生体系 国家药物政策 |
|
| International updates of developing and implementing national medicines policy and implications to China |
|
|
| Abstract:Based on the information and documents obtained from the Asia Pacific Conference on National Medicines Policies, this article reviews the development history and updates of developing and implementing national medicines policy by the international society, taking Europe and Australia as successful cases, and the explorations of other countries and areas as lessons learnt, and extracts the essence of international experiences as references for China To develop and implement national medicines policy is firstly a political process, and then a technical process; appointing implementing agency, defining clear rights and obligations, formulating feasible and operational strategies under functioning health systems are critical for a vital national medicines policy; active civil society on behalf of the consumers can play an important role in expressing public opinions, and having the National Medicines Policy contributed to better health for the people; patients centered policies and not to have consumers’ opinions to be pigeonholed can enhance their sense of identities; national medicines policy is part of the national health policy, needs comprehensive and delicate policy design to balance the health and industry objectives |
| Key words:Health policy Health system National medicines policy |
| 摘要点击次数: 2628 全文下载次数: 3557 |
|
|
